Description
Using our intelligently designed and intuitive dataset, you can quickly understand how Aspect Medical Systems Inc (RMED) is lobbying the U.S. government, how much they’re spending on it, and most importantly – the bills and specific issues on which they lobby.
Gain an informational edge with our Lobbying Data Intelligence. Perform analysis by company, lobbyist, lobbying firm, government agency, or issue.
For lobbying firms: understand your competitors. Understand who is registering with who. Gain insight on quarterly reports and specific issues other firms are lobbying on.
Our lobbying data is collected and aggregated from the U.S. Senate Office of Public Records from 1999-present and is updated on a regular basis. We utilize advanced data science techniques to ensure accurate data points are collected and ingested, match similar entities across time, and tickerize publicly traded companies that lobby.
Our comprehensive and advanced lobbying database is completed with all the information you need, with more than 1.6 million lobbying contracts ready-for-analysis. We include detailed information on all aspects of federal lobbying, including the following fascinating attributes, among much more:
1. Clients: The publicly traded company, privately owned company, interest group, NGO, or state or local government that employs or retains a lobbyist or lobbying firm.
2. Registrants (Lobbying Firms): Either the name of the lobbying firm hired by the client, or the name of the client if the client employs in-house lobbyists.
3. Lobbyists: The names and past government work experience of the individual lobbyists working on a lobbying contract. 3. General Issues: The general issues for which clients lobby on (ex: ENV – Environment, TOB – Tobacco, FAM – Family Issues/Abortion).
4. Specific Issues: A long text description of the exact bills and specific issues for which clients lobby on.
5. Bills Lobbied On: The exact congressional bills and public/private laws lobbied on, parsed from lobbying report specific issues (ex: H.R. 2347, S. 1117, Tax Cuts and Jobs Act).
6. Agencies Lobbied: The names of one or more of 250+ government agencies lobbied on in the contract (ex: White House, FDA, DOD).
7. Foreign Entities: The names and origin countries of entities affiliated with the client (ex: BNP Paribas: France).
Gain access to our highly unique and actionable U.S. lobbying database. Further information on LobbyingData.com and our alternative datasets and database can be found on our website, or by contacting [email protected].
Frequently Asked Questions
What is Aspect Medical Systems Inc (RMED) lobbying for?
Summary of Lobbying Data:
Aspect Medical Systems Inc hired lobbying firm Kountoupes Denham Carr & Reid, Llc for their 10 most recent lobbying contracts. They lobbied on general issues such as Taxation/Internal Revenue Code, Homeland Security, Health Issues, Medicare/Medicaid, and Trade (domestic/foreign). They also lobbied on specific issues including the Reconciliation Act of 2010, policy matters related to radiation therapy treatment and the Patient Centered Outcomes Research Institute, comprehensive health care reform, export markets and free trade agreements, border and port security, international tax reform, and the Responsibility & Excellence in Medical Imaging & Radiation Therapy Act of 2011. They lobbied various government agencies including the Department of State (DOS), Office of Management & Budget (OMB), White House Office, House of Representatives, Natl Economic Council (NEC), Senate, Council of Economic Advisers (CEA), and Department of Commerce (DOC).
Inference:
One could infer that Aspect Medical Systems Inc is lobbying on issues related to radiation therapy treatment and health care reform because they are a medical technology company that specializes in developing and manufacturing innovative solutions for anesthesia, patient monitoring, and pain management. They may be advocating for policies that promote and support the use of radiation therapy in medical treatment and seeking reimbursement policies that favor their products. Additionally, they may be working to ensure that health care reform initiatives do not negatively impact their business or products. Their lobbying on international trade and export markets may also be aimed at expanding their market reach and increasing sales.
